Skip to content

Imagine losing your visual connection to the world

Imagine your independence slipping away

Age-related macular degeneration is the leading cause of blindness in older adults

Imagine having difficulty reading bedtime stories to your children

Diabetic retinopathy is the leading cause of blindness in working-age adults

At Kodiak we are helping to improve millions of lives

Kodiak is designing and developing novel therapies for the treatment of retinal diseases

THE OPHTHALMOLOGY MEDICINES COMPANY


Kodiak Sciences is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases globally

OUR MISSION


Kodiak aims to prevent and treat the leading causes of blindness in the developed world

TRAILBLAZING SCIENCE

OUR CREATIVE AND THOUGHTFUL FOUNDATION

“GO-TO” MEDICINES

OUR CHALLENGE TO THE STATUS QUO

SINGULAR FOCUS IN OPHTHALMOLOGY

OUR 24/7/365

OUR PRODUCT CANDIDATES


We are committed to progressing and expanding our pipeline towards the prevention and treatment of high-prevalence ophthalmology diseases

Explore our pipeline

BIOLOGICS WITH STRONG DURABILITY: 2/3 PATIENTS ON EVERY 5 OR 6-MONTH DOSING


DESIGNED WITH WATER IN MIND

The ABC Platform is at the heart of our retinal medicines. Our bioconjugates are inspired by nature and precision engineered for increased durability and sustainable real-world efficacy

TRUE LONG-INTERVAL DOSING

Our ABC medicine has demonstrated in early and late-stage clinical studies the ability to bring nearly two thirds of patients to every 5 or 6-month dosing, unique among anti-VEGF agents

EVERY PATIENT’S GOAL

Every patient needing anti-VEGF should be considered a first-line candidate to benefit from the promise of our pipeline of next generation retinal medicines

THE ABC OF OUR SCIENCE


We are bringing new science to the design and development of next generation retinal medicines. Our Antibody Biopolymer Conjugate (ABC) Platform uses a bio-inspired polymer to enable multi-modal, multi-mechanistic treatment of complex ocular and systemic diseases.

Antibody Biopolymer Conjugate

Biopolymer
Biopolymer + Antibody
Conjugate
Conjugate + Labels

  • Designed-in durability
  • Designed to target multiple intracellular and extracellular mechanisms simultaneously
  • Designed for deeper inhibitory potency
  • Designed for ocular and systemic diseases

Learn more about the science of our ABC Platform

OUR CULTURE AND VALUES


We are actively building a place, our Kodiak Village, where we are inspired, where we feel valued, and where we can grow our personal and professional journeys while advancing our mission. Historically referred to within Kodiak as the 4 C’s, our values are:

CURIOSITY

Staying fresh. 

Asking why. 

Being naturally inquisitive.

CREATIVITY

A safe place to think outside the box. 

A focus on how to solve the problem.

COMPASSION

For ourselves. 

For our colleagues. 

For our patients.

COURAGE

Saying no when that’s the right answer. 

Saying yes when that’s the right answer.

Regardless.

WORKING AT KODIAK


We aspire to global leadership in ophthalmology through internal focus and by aggregating top talent, technologies, discoveries and ideas.